Plasma sCD14 levels in patients with BA. Quantitative analysis of soluble CD14 by ELISA in the plasma of 41 patients with early-stage biliary atresia (BA), 25 patients followed-up at the outpatient department (OPD) post-Kasai, 49 patients with late-stage BA, 9 patients with choledochal cysts (CC), and 7 healthy controls. Data represent the mean ± SD from duplicate experiments. Statistical differences were tested by nonparametric Wilcoxon matched-pairs test. *p < 0.05 and **p < 0.01 vs. late-stage BA.